FDA
- Status: approved
🇺🇸 Disease Modifying therapy in United States
Disease Modifying therapy (Disease Modifying therapy) regulatory status in United States.
Marketing authorisation
Disease Modifying therapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Disease Modifying therapy approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Disease Modifying therapy in United States?
Novartis Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.